Document is current
Any future updates will be listed below
-
Authors
Kolben, Thomas
Schröder, Lennard
Kaiser-Rix, Charlene
Mahner, Sven
Beyer, Susanne
Ehmann, Lucia
Czogalla, Bastian
Seifert, Christina
Ganster, Franziska
Kost, Bernd
Burges, Alexander
Trillsch, Fabian
Keckstein, Simon https://orcid.org/0000-0002-3333-7393
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 27 July 2025
Accepted: 19 January 2026
First Online: 2 February 2026
Declarations
:
: S. Mahner has received research support, advisory board, honoraria, and travel expenses from AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Medac, MSD, Novartis, Olympus, PharmaMar, Roche, Sensor Kinesis, Teva, and Tesaro. F. Trillsch received grants and personal fees from AbbVie, AstraZeneca, Eisai, GSK, ImmunoGen, MSD, Regeneron, Roche, and SAGA diagnostics. B. Czogalla has received speech/advisory board honoraria from AstraZeneca and MSD. All other authors declare to have no conflict of interest.
: The study was approved by the ethical committee of the University of Munich (project–nr. 22-1035, on the 11 January 2023).
: All authors have analyzed and interpreted the data and read and agreed to the published version of the manuscript.
